PCSK9-mediated degradation of the LDL receptor generates a 17 kDa C-terminal LDL receptor fragment

Proprotein convertase subtilisin/kexin type 9 (PCSK9) binds to the LDL receptor (LDLR) at the cell surface and reroutes the internalized LDLR to intracellular degradation. In this study, we have shown that PCSK9-mediated degradation of the full-length 160 kDa LDLR generates a 17 kDa C-terminal LDLR...

Full description

Bibliographic Details
Main Authors: Kristian Tveten, Thea Bismo Str⊘m, Knut Erik Berge, Trond P. Leren
Format: Article
Language:English
Published: Elsevier 2013-06-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520357126
id doaj-cc637754dbec4979bd003e79a09be416
record_format Article
spelling doaj-cc637754dbec4979bd003e79a09be4162021-04-28T06:01:07ZengElsevierJournal of Lipid Research0022-22752013-06-0154615601566PCSK9-mediated degradation of the LDL receptor generates a 17 kDa C-terminal LDL receptor fragmentKristian Tveten0Thea Bismo Str⊘m1Knut Erik Berge2Trond P. Leren3Department of Medical Genetics, Oslo University Hospital Rikshospitalet, Oslo, NorwayDepartment of Medical Genetics, Oslo University Hospital Rikshospitalet, Oslo, NorwayDepartment of Medical Genetics, Oslo University Hospital Rikshospitalet, Oslo, NorwayTo whom correspondence should be addressed; To whom correspondence should be addressed; Department of Medical Genetics, Oslo University Hospital Rikshospitalet, Oslo, NorwayProprotein convertase subtilisin/kexin type 9 (PCSK9) binds to the LDL receptor (LDLR) at the cell surface and reroutes the internalized LDLR to intracellular degradation. In this study, we have shown that PCSK9-mediated degradation of the full-length 160 kDa LDLR generates a 17 kDa C-terminal LDLR fragment. This fragment was not generated from mutant LDLRs resistant to PCSK9-mediated degradation or when degradation was prevented by chemicals such as ammonium chloride or the cysteine cathepsin inhibitor E64d. The observation that the 17 kDa fragment was only detected when the cells were cultured in the presence of the γ-secretase inhibitor DAPT indicates that this 17 kDa fragment undergoes γ-secretase cleavage within the transmembrane domain. The failure to detect the complementary 143 kDa ectodomain fragment is likely to be due to its rapid degradation in the endosomal lumen. The 17 kDa C-terminal LDLR fragment was also generated from a Class 5 mutant LDLR undergoing intracellular degradation. Thus, one may speculate that an LDLR with bound PCSK9 and a Class 5 LDLR with bound LDL are degraded by a similar mechanism that could involve ectodomain cleavage in the endosome.http://www.sciencedirect.com/science/article/pii/S0022227520357126cathepsincleavagedegradationendosomelow density lipoprotein
collection DOAJ
language English
format Article
sources DOAJ
author Kristian Tveten
Thea Bismo Str⊘m
Knut Erik Berge
Trond P. Leren
spellingShingle Kristian Tveten
Thea Bismo Str⊘m
Knut Erik Berge
Trond P. Leren
PCSK9-mediated degradation of the LDL receptor generates a 17 kDa C-terminal LDL receptor fragment
Journal of Lipid Research
cathepsin
cleavage
degradation
endosome
low density lipoprotein
author_facet Kristian Tveten
Thea Bismo Str⊘m
Knut Erik Berge
Trond P. Leren
author_sort Kristian Tveten
title PCSK9-mediated degradation of the LDL receptor generates a 17 kDa C-terminal LDL receptor fragment
title_short PCSK9-mediated degradation of the LDL receptor generates a 17 kDa C-terminal LDL receptor fragment
title_full PCSK9-mediated degradation of the LDL receptor generates a 17 kDa C-terminal LDL receptor fragment
title_fullStr PCSK9-mediated degradation of the LDL receptor generates a 17 kDa C-terminal LDL receptor fragment
title_full_unstemmed PCSK9-mediated degradation of the LDL receptor generates a 17 kDa C-terminal LDL receptor fragment
title_sort pcsk9-mediated degradation of the ldl receptor generates a 17 kda c-terminal ldl receptor fragment
publisher Elsevier
series Journal of Lipid Research
issn 0022-2275
publishDate 2013-06-01
description Proprotein convertase subtilisin/kexin type 9 (PCSK9) binds to the LDL receptor (LDLR) at the cell surface and reroutes the internalized LDLR to intracellular degradation. In this study, we have shown that PCSK9-mediated degradation of the full-length 160 kDa LDLR generates a 17 kDa C-terminal LDLR fragment. This fragment was not generated from mutant LDLRs resistant to PCSK9-mediated degradation or when degradation was prevented by chemicals such as ammonium chloride or the cysteine cathepsin inhibitor E64d. The observation that the 17 kDa fragment was only detected when the cells were cultured in the presence of the γ-secretase inhibitor DAPT indicates that this 17 kDa fragment undergoes γ-secretase cleavage within the transmembrane domain. The failure to detect the complementary 143 kDa ectodomain fragment is likely to be due to its rapid degradation in the endosomal lumen. The 17 kDa C-terminal LDLR fragment was also generated from a Class 5 mutant LDLR undergoing intracellular degradation. Thus, one may speculate that an LDLR with bound PCSK9 and a Class 5 LDLR with bound LDL are degraded by a similar mechanism that could involve ectodomain cleavage in the endosome.
topic cathepsin
cleavage
degradation
endosome
low density lipoprotein
url http://www.sciencedirect.com/science/article/pii/S0022227520357126
work_keys_str_mv AT kristiantveten pcsk9mediateddegradationoftheldlreceptorgeneratesa17kdacterminalldlreceptorfragment
AT theabismostrm pcsk9mediateddegradationoftheldlreceptorgeneratesa17kdacterminalldlreceptorfragment
AT knuterikberge pcsk9mediateddegradationoftheldlreceptorgeneratesa17kdacterminalldlreceptorfragment
AT trondpleren pcsk9mediateddegradationoftheldlreceptorgeneratesa17kdacterminalldlreceptorfragment
_version_ 1721504634756923392